Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. preclinical drug research
Show results for
Services

Companies

News

Refine by
Date

  • This week
  • This month
  • This Year
  • Older

Preclinical Drug Research Articles & Analysis

101 articles found

In vitro Cannabis Exposures of Lung Epithelial Cells at the Air-Liquid Interface

In vitro Cannabis Exposures of Lung Epithelial Cells at the Air-Liquid Interface

Abstract Cannabis is used by an estimated 192 million people around the world. Most people use cannabis through the inhalation of cannabis smoke, which contains combustion by-products that can negatively affect lung health. Knowledge of these risks has led to a growing interest in cannabis vaporizers, which heat the dry cannabis flower without burning. Vaporizing cannabis still releases ...

BySCIREQ - an emka TECHNOLOGIES Company


A New Approach to Respiratory Monitoring in Preclinical Research without restraint or acclimation

A New Approach to Respiratory Monitoring in Preclinical Research without restraint or acclimation

In preclinical respiratory studies, traditional methods like plethysmography often require animal restraint and extensive acclimation, limiting their ability to capture dynamic respiratory changes. To overcome these challenges, IPS Therapeutique Inc. validated a novel telemetry-based technique for continuous monitoring of intrapleural pressure and respiratory patterns in conscious, freely ...

BySCIREQ - an emka TECHNOLOGIES Company


ELANE Protein: A Dual-Edged Regulator of Inflammation, Immunity, and Tissue Remodeling

ELANE Protein: A Dual-Edged Regulator of Inflammation, Immunity, and Tissue Remodeling

ELANE, or neutrophil elastase (NE), is a serine protease stored in the azurophilic granules of neutrophils and is encoded by the ELANE gene on chromosome 19. It plays a pivotal role in the host defense system by degrading bacterial proteins, remodeling extracellular matrices, and shaping inflammatory responses. However, the same proteolytic activity that protects against pathogens can, when ...

ByCreative BioMart


Recombinant MGP Protein: A Key Tool for Studying Vascular Calcification and Tissue Mineralization

Recombinant MGP Protein: A Key Tool for Studying Vascular Calcification and Tissue Mineralization

Matrix Gla Protein (MGP) is a small, vitamin K-dependent extracellular matrix protein that plays a critical role in the regulation of vascular calcification and bone development. As a natural inhibitor of pathological mineralization, MGP has attracted significant attention in cardiovascular and skeletal biology research. The development of recombinant MGP protein has enabled researchers to study ...

ByCreative BioMart


Tissue Cross-Reactivity Studies: An Overview

Tissue Cross-Reactivity Studies: An Overview

Tissue cross-reactivity studies play an essential role in the understanding of immune responses, particularly in the context of autoimmunity, transplant rejection, and vaccine development. These studies aim to identify whether antibodies or T cells generated against a particular antigen react with similar proteins found in different tissues, which can lead to unintended effects and complications. ...

ByCreative Bioarray


How Lipid Metabolism Fuels Steroid Hormones and Why Their Analysis Matters

How Lipid Metabolism Fuels Steroid Hormones and Why Their Analysis Matters

Lipids, often simply thought of as fats, play a far more complex and vital role in our bodies than just energy storage. They are fundamental building blocks for cell membranes, crucial for nutrient absorption, and, significantly, the precursors to a powerful class of signaling molecules: steroid hormones. Understanding the deep connection between Lipid Metabolism and these hormones, along with ...

ByCreative Proteomics


Alfa Cytology Introduces Specialized Therapeutic Development Services Targeting FAP for Precision Oncology Treatments

Alfa Cytology Introduces Specialized Therapeutic Development Services Targeting FAP for Precision Oncology Treatments

Alfa Cytology works to establish cooperative relationships between academic institutions and research organizations. According to active collaboration with scientists and clinical experts, the company promotes innovation and speeds up laboratory discoveries to help preclinical practice. ...

ByAlfa Cytology


Refining the Study of Myocardial Infarction in Sheep

Refining the Study of Myocardial Infarction in Sheep

Ischaemic heart diseases continue to be a major global health concern and a leading cause of death. To develop more effective treatments, it is essential for researchers to work with animal models that closely replicate human cardiac physiology. In a notable step forward, Pius et al. present a refined, minimally invasive ovine model of ischaemia–reperfusion–infarction which ...

Byemka Technologies S.A.S


Alfa Cytology Introduces Full-Scale ADCs Development Services Focused on Cancer Therapy

Alfa Cytology Introduces Full-Scale ADCs Development Services Focused on Cancer Therapy

Alfa Cytology maintains a commitment to creating collaborative partnerships with academic institutions and research organizations. The company seeks to advance innovation and improve the preclinical implementation of laboratory breakthroughs through its collaboration with scientists and oncologists. ...

ByAlfa Cytology


Advancing Cancer Treatment: The Role of Radioactive Drug Conjugate Development Services and Pre-Clinical Analysis Services for RDCs

Advancing Cancer Treatment: The Role of Radioactive Drug Conjugate Development Services and Pre-Clinical Analysis Services for RDCs

Understanding Radioactive Drug Conjugates Radioactive drug conjugates are engineered to deliver radiation directly to cancer cells while sparing healthy tissues. ...

ByAlfa Cytology


Alfa Cytology Unveils Advanced PD-1 Inhibitor Development Service for Cancer Research

Alfa Cytology Unveils Advanced PD-1 Inhibitor Development Service for Cancer Research

“We are excited to provide researchers with access to advanced technologies and extensive support crucial for their transformative studies.” In summary, Alfa Cytology excels in delivering vital services for cancer immunotherapy and cell therapy research, enabling scientists and researchers to push the boundaries of current knowledge and develop ...

ByAlfa Cytology


Comprehensive Disease Models for Preclinical Drug Discovery

Comprehensive Disease Models for Preclinical Drug Discovery

Preclinical drug discovery represents a critical phase in the development of new therapeutics. It is the process that bridges the gap between basic research and clinical testing, allowing for the evaluation of potential drug candidates in biological systems before they are tested in humans. ...

ByCreative Biogene


Drug Screening in Animal Models: A Crucial Step in Biomedical Research

Drug Screening in Animal Models: A Crucial Step in Biomedical Research

For instance, larger animals such as dogs or pigs are often preferred in the study of cardiology, while zebrafish provide a rapid assessment of pharmacokinetics and toxicity. Phases of Drug Screening Drug screening typically unfolds in several key phases: Preclinical Testing: Before any drug can enter human trials, it undergoes ...

ByCreative Biogene


Alfa Cytology Unveils Advanced Ovarian Cancer Therapy Development Services

Alfa Cytology Unveils Advanced Ovarian Cancer Therapy Development Services

These services include developing targeted therapies, immunotherapy, and inhibitors and drugs. Each stage must undergo rigorous quality testing to achieve the highest safety standards. ...

ByAlfa Cytology


Alfa Cytology Unveils Advanced Cancer Immunotherapy Development Services

Alfa Cytology Unveils Advanced Cancer Immunotherapy Development Services

These avant-garde solutions are built upon a profound understanding of tumor immunology and cellular signaling pathways, empowering researchers to strengthen research on experimental therapies. “Our cancer immunotherapy development services embody our unwavering commitment to empowering oncology research and innovation,” stated the ...

ByAlfa Cytology


Unveiling the Future of Leukemia: Advancements in Immunotherapy and Beyond 

Unveiling the Future of Leukemia: Advancements in Immunotherapy and Beyond 

Leukemia, a malignant disorder of the blood and bone marrow, poses significant challenges to both patients and healthcare providers. Traditional treatments, including chemotherapy and radiation, while effective for some, often come with severe side effects and varied success rates. Enter immunotherapy - a groundbreaking approach that is not only redefining leukemia treatment but also offering ...

ByAlfa Cytology


The challenge of cardiovascular toxicity evaluation

The challenge of cardiovascular toxicity evaluation

The evaluation of cardiovascular toxicity is a significant challenge in drug development. Preclinical evaluation of cardiovascular safety involves a multifaceted approach, encompassing a plethora of in vitro and in vivo endpoints. These assessments continuously evolve, aiming to mitigate the incidence of cardiovascular toxicity that may emerge during clinical trials. To shed light on the ...

Byemka Technologies S.A.S


Alfa Cytology Launches Innovative Bladder Cancer Therapeutic Antibody Development Services

Alfa Cytology Launches Innovative Bladder Cancer Therapeutic Antibody Development Services

The service encompasses the entire preclinical development lifecycle of therapeutic antibodies—ranging from initial conceptualization and engineering to rigorous quality assurance assessments. ...

ByAlfa Cytology


Advancements in Breast Cancer Research: The Role of Tumor Models and Customized ADCs Development Services

Advancements in Breast Cancer Research: The Role of Tumor Models and Customized ADCs Development Services

Breast cancer remains one of the most prevalent malignancies affecting women worldwide, necessitating innovative approaches for effective treatment and research. Among the most promising strategies in this endeavor are the use of tumor models for breast cancer and the development of customized antibody-drug conjugates (ADCs). ...

ByAlfa Cytology


Premade AAV Particles: Revolutionizing Gene Therapy

Premade AAV Particles: Revolutionizing Gene Therapy

In recent years, adeno-associated virus (AAV) particles have emerged as a pivotal tool in the realm of gene therapy, offering researchers and clinicians innovative approaches to treat a variety of genetic disorders. Premade AAV particles represent a significant advancement in this field, streamlining the process of gene delivery and significantly enhancing the efficiency and efficacy of ...

ByCreative Biogene

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT